Advancing data discovery in the life sciences through artificial intelligence
Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…
CertaraMarch 2, 2023
Certara Announces Transition Plan For Chief Financial Officer
PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…
CertaraMarch 1, 2023
Learn how to create CDISC domains in minutes with PK Submit
Creating CDISC domains as part of the pharmacokinetic (PK) deliverable for regulatory submissions can be…
CertaraMarch 1, 2023
Understanding Europe’s New Clinical Trial Regulations (EU-CTR)
While the new EU-CTR will help to streamline clinical trials, which will benefit both patients…
CertaraFebruary 27, 2023
Common Clinical Trial Disclosure Challenges & Potential Solutions
Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…
CertaraFebruary 24, 2023
FDA Modernization Act 2.0 – What does it mean for drug developers?
Historically, the FDA has required drug discovery and development programs to include animal testing. This…
CertaraFebruary 21, 2023
RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act
The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…
CertaraFebruary 10, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
CertaraFebruary 9, 2023
